Deccan Health Care Ltd
Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer health products[1]
- Market Cap ₹ 44.6 Cr.
- Current Price ₹ 19.0
- High / Low ₹ 32.9 / 16.0
- Stock P/E 43.3
- Book Value ₹ 45.4
- Dividend Yield 0.00 %
- ROCE 1.65 %
- ROE 1.14 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.42 times its book value
- Company is expected to give good quarter
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -1.04%
- Promoter holding is low: 18.4%
- Company has a low return on equity of 1.10% over last 3 years.
- Contingent liabilities of Rs.16.8 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|
42.24 | 33.78 | 33.17 | 45.02 | 59.73 | 75.06 | 82.14 | |
30.57 | 31.74 | 27.54 | 43.06 | 55.97 | 71.92 | 79.08 | |
Operating Profit | 11.67 | 2.04 | 5.63 | 1.96 | 3.76 | 3.14 | 3.06 |
OPM % | 27.63% | 6.04% | 16.97% | 4.35% | 6.29% | 4.18% | 3.73% |
0.06 | 0.06 | -3.46 | 0.02 | 0.01 | 0.01 | 0.01 | |
Interest | 0.18 | 0.11 | 0.15 | 0.11 | 0.09 | 0.07 | 0.09 |
Depreciation | 1.42 | 1.47 | 1.47 | 1.43 | 1.47 | 1.45 | 1.51 |
Profit before tax | 10.13 | 0.52 | 0.55 | 0.44 | 2.21 | 1.63 | 1.47 |
Tax % | 0.39% | 25.00% | 40.00% | 31.82% | 33.03% | 28.83% | |
10.09 | 0.39 | 0.32 | 0.31 | 1.49 | 1.16 | 1.03 | |
EPS in Rs | 6.42 | 0.25 | 0.20 | 0.18 | 0.73 | 0.50 | 0.46 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 12% |
3 Years: | 31% |
TTM: | 29% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -35% |
3 Years: | -20% |
TTM: | -34% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -16% |
3 Years: | -16% |
1 Year: | -41% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 1% |
3 Years: | 1% |
Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 15.71 | 15.71 | 15.71 | 17.04 | 20.38 | 23.43 |
Reserves | 60.52 | 60.91 | 61.23 | 64.52 | 76.53 | 82.97 |
0.87 | 1.03 | 1.25 | 1.61 | 1.90 | 1.14 | |
15.89 | 14.61 | 12.44 | 13.62 | 9.24 | 17.39 | |
Total Liabilities | 92.99 | 92.26 | 90.63 | 96.79 | 108.05 | 124.93 |
21.25 | 19.87 | 18.53 | 16.85 | 15.69 | 14.38 | |
CWIP | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 37.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
33.84 | 72.32 | 72.10 | 79.94 | 92.36 | 110.55 | |
Total Assets | 92.99 | 92.26 | 90.63 | 96.79 | 108.05 | 124.93 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
2.68 | 0.22 | -0.57 | -6.76 | -12.55 | -6.43 | |
-1.94 | -0.07 | -0.05 | 0.27 | -0.30 | -0.14 | |
-1.77 | -0.37 | 0.07 | 5.26 | 14.04 | 7.52 | |
Net Cash Flow | -1.03 | -0.22 | -0.56 | -1.23 | 1.19 | 0.95 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 177.66 | 134.74 | 141.07 | 97.21 | 60.44 | 60.98 |
Inventory Days | 0.00 | 890.81 | 1,182.75 | 683.64 | 445.05 | 327.35 |
Days Payable | 112.09 | 147.78 | 123.28 | 41.68 | 69.00 | |
Cash Conversion Cycle | 177.66 | 913.46 | 1,176.04 | 657.58 | 463.81 | 319.32 |
Working Capital Days | 421.77 | 545.99 | 603.01 | 507.69 | 477.19 | 423.01 |
ROCE % | 0.81% | 5.62% | 0.68% | 2.53% | 1.65% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Aug - Financial Results For the Quarter ended on 30th June, 2025
- Results For The Quarter Ended June 2025 14 Aug
-
Board Meeting Outcome for Outcome Of Board Meeting
14 Aug - Approved and submitted Q1 FY26 standalone and consolidated unaudited financial results with limited review reports.
-
Board Meeting Intimation for To Consider And Approve Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June 2025.
8 Aug - Board meeting on 14 Aug 2025 to approve Q1 FY26 unaudited financial results.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
14 Jul - Certificate confirming all shares dematerialized; no demat/remat requests for quarter ended June 30, 2025.
Business Overview:[1]
DHL is a Nutraceutical and wellness product company. Its food pills and meals are categorized under Fast Moving Consumer Healthcare (FMCH) products and covers 52 consumer wellness goals preventing over 200 diseases, disorders and disabilities due to micro nutritional deficiency. Company does sales of its Be Young brand through e-commerce platform www.beyoungstore.com